SHOULDER INNOVATIONS, INC. (SI) Current Ratio
- Current ratio · latest quarter: Value 10.71×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 10.71× | Current assets / current liabilities. $137.41M ÷ $12.83M ≈ 10.71× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 137.41M USD | Assets, Current |
| Current obligations | 12.83M USD | Liabilities, Current |
| Cash and equivalents | 24.46M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | 74.53M USD | Debt Securities, Available-for-sale, Current |
| Customer receivables | 10.87M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | 22.92M USD | Inventory, Net |
| Payables | 5.93M USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $137.41M | $12.83M | $24.46M | $74.53M | $10.87M | $22.92M | $5.93M | (m) | 10.71× |
| 2026-03-31 | $145.78M | $12.34M | $11.49M | $97.05M | $10.55M | $21.83M | $5.92M | (m) | 11.81× |
| 2025-12-31 | $157.16M | $14.20M | $26.87M | $97.43M | $8.27M | $21.59M | $8.87M | (m) | 11.07× |
| 2025-09-30 | $166.61M | $15.02M | $54.93M | $82.35M | $7.08M | $19.36M | $8.88M | (m) | 11.09× |
| 2025-06-30 | $68.91M | $12.49M | $27.05M | $12.58M | $6.89M | $17.08M | $6.04M | (m) | 5.52× |
| 2024-12-31 | $35.13M | $7.65M | $6.12M | $8.92M | $5.12M | $13.96M | $4.86M | (m) | 4.59× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |